Gabbita, S., Aksenov, M., Lovell, M., & Markesbery, W. (1999). Decrease in peptide methionine sulfoxide reductase in Alzheimer’s disease brain. Journal of Neurochemistry, 73(4), 1660-6. https://doi.org/10.1046/j.1471-4159.1999.0731660.x

Lovell, M., Xie, C., & Markesbery, W. (2000). Decreased base excision repair and increased helicase activity in Alzheimer’s disease brain. Brain Research, 855(1), 116-23. https://doi.org/10.1016/s0006-8993(99)02335-5 (Original work published 2000)

Lovell, M., Xie, C., Gabbita, S., & Markesbery, W. (2000). Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer’s disease brain. Free Radical Biology & Medicine, 28(3), 418-27. https://doi.org/10.1016/s0891-5849(99)00258-0 (Original work published 2000)

Xie, C., Markesbery, W., & Lovell, M. (2000). Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium. Free Radical Biology & Medicine, 28(5), 665-72. https://doi.org/10.1016/s0891-5849(99)00268-3 (Original work published 2000)

Lovell, M., Xie, C., & Markesbery, W. (2000). Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radical Biology & Medicine, 29(8), 714-20. https://doi.org/10.1016/s0891-5849(00)00346-4 (Original work published 2000)

Lovell, M., Xie, C., & Markesbery, W. (1969). Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures. Neurobiology of Aging, 22(2), 187-94. https://doi.org/10.1016/s0197-4580(00)00235-9 (Original work published 1969)

Lange, M. B., St Clair, D., Markesbery, W., Studzinski, C., Murphy, M., & Butterfield, D. (2010). Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease. Neurobiology of Disease, 38(1), 104-15. https://doi.org/10.1016/j.nbd.2010.01.004

Keller, J., Schmitt, F., Scheff, S., Ding, Q., Chen, Q., Butterfield, D., & Markesbery, W. (2005). Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology, 64(7), 1152-6. https://doi.org/10.1212/01.WNL.0000156156.13641.BA (Original work published 2005)

Sultana, R., Boyd-Kimball, D., Poon, H., Cai, J., Pierce, W., Klein, J., … Butterfield, D. (2006). Oxidative modification and down-regulation of Pin1 in Alzheimer’s disease hippocampus: A redox proteomics analysis. Neurobiology of Aging, 27(7), 918-25. https://doi.org/10.1016/j.neurobiolaging.2005.05.005

Sultana, R., Boyd-Kimball, D., Poon, H., Cai, J., Pierce, W., Klein, J., … Butterfield, D. (2006). Redox proteomics identification of oxidized proteins in Alzheimer’s disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiology of Aging, 27(11), 1564-76. https://doi.org/10.1016/j.neurobiolaging.2005.09.021